Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research
AuthorGuerin, AA; Bonomo, Y; Lawrence, AJ; Baune, BT; Nestler, EJ; Rossell, SL; Kim, JH
Source TitleFrontiers in Psychiatry
PublisherFRONTIERS MEDIA SA
University of Melbourne Author/sGuerin, Alexandre; Lawrence, Andrew; Rossell, Susan; Kim, Jee Hyun; Baune, Bernhard
AffiliationCentre for Youth Mental Health
Florey Department of Neuroscience and Mental Health
Melbourne School of Psychological Sciences
Document TypeJournal Article
CitationsGuerin, A. A., Bonomo, Y., Lawrence, A. J., Baune, B. T., Nestler, E. J., Rossell, S. L. & Kim, J. H. (2019). Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research. FRONTIERS IN PSYCHIATRY, 10, https://doi.org/10.3389/fpsyt.2019.00880.
Access StatusOpen Access
Despite the prevalence of methamphetamine (meth) use disorder, research on meth is disproportionately scarce compared to research on other illicit drugs. Existing evidence highlights cognitive deficits as an impediment against daily function and treatment of chronic meth use. Similar deficits are also observed in schizophrenia, and this review therefore draws on schizophrenia research by examining similarities and differences between the two disorders on cognition and related neural findings. While meth use disorder and schizophrenia are two distinct disorders, they are highly co-morbid and share impairments in similar cognitive domains and altered brain structure/function. This narrative review specifically identifies overlapping features such as deficits in learning and memory, social cognition, working memory and inhibitory/impulse control. We report that while working memory deficits are a core feature of schizophrenia, such deficits are inconsistently observed following chronic meth use. Similar structural and functional abnormalities are also observed in cortical and limbic regions between the two disorders, except for cingulate activity where differences are observed. There is growing evidence that targeting cognitive symptoms may improve functional outcome in schizophrenia, with evidence of normalized abnormal brain activity in regions associated with cognition. Considering the overlap between meth use disorder and schizophrenia, targeting cognitive symptoms in people with meth use disorder may also improve treatment outcome and daily function.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References